Skip to Content

BioNTech to work with Senegal, Rwanda to make mRNA vaccines


Associated Press

DAKAR, Senegal (AP) — Senegal and Rwanda have signed an agreement with German company BioNTech for the construction of its first start-to-finish factories to make messenger RNA vaccines in Africa. BioNTech, which developed and produces the Pfizer-BioNTech COVID-19 vaccine, said Tuesday that construction on the facilities will start in mid-2022. It said in a statement that it is working with the Institut Pasteur in Dakar, Senegal’s capital, and the Rwandan government. Matshidiso Moeti, the World Health Organization’s Regional Director for Africa, welcomed the announcement. She said state-of-the-art facilities will be life-savers and game-changers for Africa and could lead to millions of cutting-edge vaccines being made for Africans, by Africans in Africa. 

Article Topic Follows: AP National News

Jump to comments ↓

Associated Press


KTVZ NewsChannel 21 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content